| Literature DB >> 20978065 |
Rogier M van Rijn1, John van Ochten, Pim A J Luijsterburg, Marienke van Middelkoop, Bart W Koes, Sita M A Bierma-Zeinstra.
Abstract
OBJECTIVE: To summarise the effectiveness of adding supervised exercises to conventional treatment compared with conventional treatment alone in patients with acute lateral ankle sprains.Entities:
Mesh:
Year: 2010 PMID: 20978065 PMCID: PMC2965125 DOI: 10.1136/bmj.c5688
Source DB: PubMed Journal: BMJ ISSN: 0959-8138

Fig 1 Flow chart of selected articles

Fig 2 Assessment of risk of bias
Assessment of risk of bias in individual studies on treatment of ankle sprain, with scores per item
| Authors | Adequate randomisation | Allocation concealed | Blinding | Drop-out rate described | Intention to treat analysis | Groups similar at baseline | Co-interventions avoided | Compliance acceptable | Timing of outcome assessment similar | Total score | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient | Care provider | Outcome assessor | ||||||||||
| Basset et al22 | Yes | Unsure | No | No | No | Yes | Unsure | No | Unsure | Yes | Unsure | 3 |
| Brooks et al23 | Unsure | Unsure | No | No | No | No | Unsure | Unsure | Yes | Unsure | Yes | 2 |
| Holme et al24 | Yes | Unsure | No | No | No | Yes | Yes | Yes | Unsure | Unsure | Yes | 4 |
| Hultman et al30 | No | Unsure | No | No | No | No | Unsure | Unsure | Unsure | Unsure | Yes | 1 |
| Karlsson et al21 | Unsure | Unsure | No | No | No | Yes | Unsure | Unsure | Unsure | Unsure | No | 1 |
| Nilsson25 | Unsure | Unsure | No | No | No | Yes | Yes | Unsure | No | Unsure | No | 2 |
| Oostendorp26 | Unsure | Unsure | No | No | No | Unsure | Unsure | Unsure | Unsure | Unsure | Yes | 1 |
| Reinhardt et al27 | Unsure | Unsure | No | No | No | Yes | Unsure | Unsure | Unsure | Unsure | Yes | 2 |
| Roycroft et al28 | Unsure | Unsure | No | No | No | No | Unsure | Unsure | Unsure | Unsure | Yes | 1 |
| van Rijn et al20 | Yes | Yes | No | No | No | Yes | Yes | Unsure | Unsure | Yes | Yes | 6 |
| Wester et al29 | Yes | Unsure | No | No | No | No | Unsure | Unsure | Yes | Unsure | Yes | 3 |
Characteristics of included studies
| Author | Study population | Conventional treatment | Supervised treatment |
|---|---|---|---|
| Basset et al22 | 47 (of 52 enrolled) patients with acute ankle sprain (first time or recurrent) recruited from 4 physical therapy clinics in middle to low socioeconomic suburbs: 60% male; mean (SD) age 30 (12.4); injury grade: 38% mild, 51% moderate, 11% severe; re-sprain 55% | Home based intervention programme. Small home programme of no more than 4 simple activities. Equipment such as strapping tape, Tubigrip for compression, Thera-band resistance bands, and wobble boards. Treatment booklet; information about structure of ankle, ankle sprains, diary grids, progress sheets, adherence enhancing, and 3 treatment phases: 1—acute (36-48 hours): RICE, and active ankle movements within limits of pain; 2—mobilising (10-14 days): mobilising and strengthening exercises, calf and heel stretches, ankle strapping/taping; 3—strengthening (10-14 days): Thera-band resistance, bodyweight resistance in standing, one leg standing, standing on wobble board, weight bearing activities, ankle strapping | Clinic based intervention programme. Small home programme of no more than 4 simple activities. Physical therapist treated symptoms, and supervised activities/exercises of 3 phase physical therapy programme: 1—acute (36-48 hours): RICE, and active ankle movements within limits of pain; mobilising (10-14 days): 2—mobilising and strengthening exercises, calf and heel stretches, ankle strapping/taping; 3—strengthening (10-14 days): Thera-band resistance, bodyweight resistance in standing, one leg standing, standing on wobble board, weight bearing activities, ankle strapping |
| Brooks et al23 | 102 (241) patients with inversion injury, with talar tilt <15°, who attended local emergency department, age 12-65 | Treatment groups: 1—no treatment, no support or only minimal bandage; 2—double Tubigrip support to wear during daytime and advised to remove in bed at night; 3—ankle completely immobilised in below knee plaster of Paris cast, but patients encouraged to bear weight as soon as possible | First day or within 48 hours of presentation: iced foot bath, mobilisation, instruction in normal gait. Second or third visit: wobble board exercises. Treatment considered complete when patient could tolerate 10 minutes on wobble board |
| Holme et al24 | 71 (92) patients, all recreational athletes, with ankle sprain sustained during sports who attended local emergency department: 62% male; mean age 26.5; injury grade: 30% mild, 53% moderate, 17% severe | Information regarding early ankle mobilisation, including strength, mobility, and balance exercises | Information regarding early ankle mobilisation, including strength, mobility, and balance exercises, combined with supervised group physical therapy rehabilitation (1 hour, twice weekly): comprehensive balance exercises on both legs, figure of eight running; standing on balance board and catching ball, standing on outside of feet, standing on inside of feet with open and closed eyes |
| Hultman et al30 | 65 (115) with ankle sprain who attended emergency department: 54% male; mean (range) age 35 (18-65) | Examination of ankle, initial weight unloading with crutches, elastic wrap, and verbal and/or written information from attending physician or nurse about mobilisation and early weight bearing, followed by two visits to physiotherapist (6 weeks, 3 months): early range of motion training, weight bearing on injured ankle, balance and strength training, instructions for home exercises | Examination of ankle, initial weight unloading with crutches, elastic wrap, and verbal and/or written information from attending physician or nurse about mobilisation and early weight bearing, followed by four visits to physiotherapist (baseline, 3 weeks, 6 weeks, 3 months): early range of motion training, weight bearing on injured ankle, balance and strength training, instructions for home exercises |
| Karlsson et al21 | 84 (86) consecutive patients, active in sports on recreational or competitive level, with ligament ruptures of ankle: 66% male; mean (range) age 22 (16-38); injury grade: 59% moderate, 41% severe | Elastic wrapping, partial weight bearing, and crutches until pain subsided | Functional treatment: compression pads, early weight-bearing. Range of motion training: dorsal and plantar flexion, supination, proprioceptive training, standing on one leg with eyes closed, walking along zig-zag lines. Strength training: rubber cords, weight boots |
| Nilsson25 | 118 (180) patients with injury to lateral ankle ligaments (classified as “rupture” or “no rupture”) within past 6 hours, who attended local emergency department: 59% male; mean (range) age 33.6 (15-66) | Elastic wrapping only (n=59) | Elastic wrapping and cryotherapy combined with physiotherapy starting on 5th day after injury: limbering exercises of ankle, ultrasound treatment to lateral side of ankle, coordination exercises, strengthening exercises of fibular muscles (n=59). Each session lasted 45 mins and was given daily until patient was symptom free or had received 10 treatments |
| Oostendorp26 | 24 (24) patients with inversion injury of ankle, sustained during volleyball, basketball, handball, or soccer, who attended physical therapy practices: 67% male; mean (range) age 22.1 (15-30) | Cryotherapy, compression bandage and minimal weight bearing followed by 6 week tape bandage | Cryotherapy, compression bandage, and minimal weight bearing followed by 6 week tape bandage combined with standardised progressive training program (3 physical therapy sessions/week, daily home exercises): stability exercises, disturbance in balance, variation in posture, visual control), isometric strengthening exercises, manual resistance |
| Reinhardt et al27 | 72 (80) patients, consisting of recruits and professional soldiers, with acute ankle sprain: mean age 22.6 | Early functional treatment: Aircast brace, non-weight bearing, cryotherapy, elevation for 3-5 days | Early functional treatment: Aircast-brace, non-weight bearing, cryotherapy, elevation for 3-5 days. Six physical therapy sessions: proprioceptive training (balance board, rough terrain), limbering exercises, strengthening exercises, home exercises (n=47) |
| Roycroft et al28 | 43 (98) patients with inversion injuries of ankle who attended local emergency department: injury grade: 47.5% mild, 52.5% moderate | Wool and elastoplasts bandage or plaster of Paris backslab, non-weight bearing (n=37) | Immediate active treatment (RICE) and full weight bearing, after 24 hours referred to physical therapy: ultrasonography, taping, Tubigrip support, mobilisation and rehabilitation (n=43) |
| van Rijn et al20 | 102 (107) patients with acute lateral ankle sprain, who attended GP or local emergency department: 58% male; mean age 37.0; injury grade 42% mild, 40% moderate, 4% severe, 14% unknown | Early ankle mobilisation, home exercises, early weight bearing, and tape, bandage, or brace (n=53) | Early ankle mobilisation, home exercises, early weight bearing, and tape, bandage, or brace. Progressive training programme supervised by physiotherapist (max 9 half hour sessions, within 3 months): balance exercises, walking, running, jumping (n=49) |
| Wester et al29 | 48 (61) patients, active in sports >2 hour/week, with primary ankle sprain who attended local emergency department: 60% male; mean (SD) age 25 (7.2); injury grade: moderate | Compression bandage for 1 week, leg elevation and immobilisation for 2 days, avoiding activities straining lateral ligaments, and return to sport activities not permitted until activities of daily living possible without pain. | Compression bandage for 1 week, leg elevation and immobilisation for 2 days, avoiding activities straining lateral ligaments, and return to sports activities not permitted until activities of daily living possible without pain, 12 week training programme (15 min/day), with wobble board |
RICE=rest, ice, compression, elevation.
Results of best evidence synthesis from randomised controlled trials on treatment of ankle sprain
| Outcome and follow-up* | Effectiveness† (risk of bias) | Best evidence synthesis |
|---|---|---|
| Short term | No (high25 29) | Moderate evidence of no effectiveness |
| Intermediate | Yes (high26), no (high,29 low20 ) | Conflicting evidence |
| Long term | No (high,25 26 low20) | Moderate evidence of no effectiveness |
| Short term | — | No available evidence |
| Intermediate | No (high,26 27 low20) | Moderate evidence of no effectiveness |
| Long term | Yes (high25), no (high,26 29 low20 ) | Conflicting evidence |
| Short term | Yes (high28) | Limited evidence of effectiveness |
| Intermediate | No (low20) | Limited evidence of no effectiveness |
| Long term | No (low20) | Limited evidence of no effectiveness |
| Short term | No (high22), yes (high30) | Conflicting evidence |
| Intermediate | — | No available evidence |
| Long term | No (high21) | Limited evidence of no effectiveness |
| Short term | — | No available evidence |
| Intermediate | No (high27 ,low20) | Moderate evidence of no effectiveness |
| Long term | Yes (high24), no (high,25 29 low20) | Conflicting evidence |
| Short term | NA (high21 25), yes (high23 27), no (high30) | Conflicting evidence |
| Intermediate | No (high26) | Limited evidence of no effectiveness |
| Long term | No (high26) | Limited evidence no effectiveness |
| Short term | Yes (high21), NA (high27) | Limited evidence of effectiveness |
| Intermediate | Yes at 6 weeks, no at 12 weeks (high26)‡ | Conflicting evidence |
| Long term | No (high26) | Limited evidence of no effectiveness |
NA=not applicable because of incomplete data.
*Short term=up to 2 weeks; intermediate=2 weeks to 3 months; long term=more than 3 months.
†Effectiveness of conventional treatment combined with supervised exercises compared with conventional treatment alone.
‡Study measured return to sport at 6 and 12 weeks, both of which are part of intermediate term follow-up. No differences between treatment groups found at 6 weeks, whereas significant difference in favour of supervised exercises found at 12 weeks.
Results of individual studies with pain as outcome measure classified by duration of follow-up
| Outcome | Conventional treatment | Supervised treatment | Relative risk or effect size* (95% CI) |
|---|---|---|---|
| Nillson25 | |||
| No (%) with pain at 7 days | 38 (64.4) | 31 (52.5) | 0.82 (0.60 to 1.11) |
| Wester29 | |||
| No (%) with pain at 7 days: | |||
| At rest | 7 (29) | 12 (50) | 1.71 (0.82 to 3.60) |
| Walking | 20 (83) | 20 (83) | 1.00 (0.78 to 1.29) |
| Sports | 23 (96) | 23 (96) | 1.00 (0.89 to 1.13) |
| Oostendorp26 | |||
| Mean (SD) pain (VAS 0-100): | |||
| At 6 weeks | 25 (5) | 18 (7) | 1.11† (0.25 to 1.97)‡ |
| At 12 weeks | 15 (7) | 9 (8) | 0.77† (−0.06 to 1.60) |
| van Rijn20 | |||
| Mean (SD) pain (VAS 0-10) at 3 months: | |||
| At rest§ | 0.4 (1.0) | 0.3 (1.2) | 0.14† (−0.28 to 0.56) |
| Walking flat§ | 0.4 (1.0) | 0.4 (1.3) | 0.04† (−0.38 to 0.47) |
| Walking rough§ | 1.3 (1.7) | 0.8 (1.3) | 0.30† (−0.13 to 0.72) |
| Mean (SD) pain in subgroup AFS ≤40 (severe) at 8 weeks: | |||
| At rest | 1.5 (2.6) | 0.5 (1.0) | 0.50† (−0.03 to 1.03) |
| Walking flat | 1.2 (1.9) | 0.6 (1.2) | 0.37† (−0.16 to 0.90) |
| Walking rough | 3.1 (2.4) | 1.7 (1.9) | 0.64† (0.10 to 1.17)‡ |
| Mean (SD) pain in subgroup AFS >40 (mild) at 8 weeks: | |||
| At rest | 0.6 (1.5) | 0.2 (0.7) | 0.31† (−0.27 to 0.89) |
| Walking flat | 0.5 (1.5) | 0.3 (0.6) | 0.17† (−0.41 to 0.75) |
| Walking rough | 1.5 (2.3) | 1.1 (1.7) | 0.19† (−0.39 to 0.77) |
| Wester29 | |||
| No (%) with pain: | |||
| At rest, 6 weeks | 0 (0) | 1 (4) | NA |
| At rest, 12 weeks | 1 (4) | 0 (0) | NA |
| Walking, 6 weeks | 5 (21) | 6 (25) | 1.20 (0.42 to 3.41) |
| Walking, 12 weeks | 1 (4) | 1 (4) | 1.00 (0.07 to 15.08) |
| Sports, 6 weeks | 18 (75) | 18 (75) | 1.00 (0.72 to 1.39) |
| Sports, 12 weeks | 7 (29) | 4 (17) | 0.57 (0.19 to 1.70) |
| Nillson25 | |||
| No (%) with pain: | |||
| At 3-6 months | 19 (32.2) | 18 (30.5) | 0.95 (0.56 to 1.62) |
| At 3 years | 8 (15.7) | 5 (9.4) | 0.60 (0.21 to 1.72) |
| Oostendorp26 | |||
| Mean (SD) pain (VAS 0-100) at 24 weeks | 10 (6) | 6 (4) | 0.76† (−0.07 to 1.59) |
| van Rijn20 | |||
| Mean (SD) pain (VAS 0-10) at 12 months: | |||
| At rest§ | 0.3 (0.8) | 0.3 (0.9) | 0.02† (−0.44 to 0.48) |
| Walking flat§ | 0.2 (0.7) | 0.3 (0.9) | −0.10† (−0.56 to 0.36) |
| Walking rough§ | 0.8 (1.4) | 0.9 (2.1) | −0.05† (−0.51 to 0.41) |
| Mean (SD) pain in subgroup AFS ≤40 (severe) at 12 months: | |||
| At rest | 0.4 (0.8) | 0.3 (0.9) | 0.12† (−0.41 to 0.64) |
| Walking flat | 0.2 (0.7) | 0.3 (1.0) | −0.11† (−0.64 to 0.41) |
| Walking rough | 1.0 (1.5) | 0.9 (2.3) | 0.05† (−0.47 to 0.57) |
| Mean (SD) pain in subgroup AFS >40 (mild): | |||
| At rest | 0.1 (0.6) | 0.4 (0.9) | −0.39† (−0.98 to 0.19) |
| Walking flat | 0.3 (0.8) | 0.1 (0.5) | 0.29† (−0.29 to 0.87) |
| Walking rough | 0.8 (1.5) | 1.0 (2.1) | −0.11† (−0.69 to 0.47) |
NA=not applicable; VAS=visual analogue scale; AFS=ankle function score.
*Effect size >0 indicates beneficial effects of supervised treatment; relative risk <1.0 indicates beneficial effects of supervised treatment.
†Effect size.
‡P<0.05.
§Double publication showed known that data on pain were available at certain follow-up times; data obtained after request to authors.
Results of individual studies with instability as outcome measure classified by duration of follow-up
| Outcome | Conventional treatment | Supervised treatment | Relative risk or effect size* (95% CI) |
|---|---|---|---|
| Oostendorp26 | |||
| No (%) with fear of giving way: | |||
| At 6 weeks | 8 (67) | 3 (25) | 0.38 (0.13 to 1.08) |
| At 12 weeks | 5 (42) | 2 (17) | 0.40 (0.10 to 1.67) |
| Reinhardt27 | |||
| No (%) with instability at 3 months | 5 (15) | 2 (4) | 0.28 (0.06 to 1.36) |
| van Rijn20 | |||
| No (%) with instability at 3 months | 32 (65) | 34 (64) | 1.02 (0.76 to 1.36) |
| Mean (SD) instability (VAS 0-10) in subgroup AFS ≤40 (severe) at 8 weeks: | |||
| Walking flat | 1.4 (1.6) | 0.3 (0.8) | 0.86† (0.31 to 1.40)‡ |
| Walking rough | 2.8 (2.1) | 1.6 (1.6) | 0.63† (0.10 to 1.17)‡ |
| Mean (SD) instability (VAS 0-10) in subgroup AFS >40 (mild) at 8 weeks: | |||
| Walking flat | 0.7 (1.2) | 0.4 (0.9) | 0.27† (−0.31 to 0.86) |
| Walking rough | 1.6 (2.1) | 1.2 (1.4) | 0.22† (−0.37 to 0.80) |
| Nilsson25 | |||
| No (%) with instability at 3-6 months | 12 (20.3) | 14 (23.7) | 1.17 (0.59 to 2.30) |
| No (%) with instability at 3 years | 12 (23.5) | 7 (13.2) | 0.56 (0.24 to 1.31) |
| Oostendorp26 | |||
| No (%) with fear of giving way at 24 weeks | 5 (42) | 1 (8) | 0.20 (0.03 to 1.47) |
| van Rijn20 | |||
| No (%) with instability at 12 months | 26 (53) | 30 (57) | 1.06 (0.75 to 1.52) |
| Mean (SD) instability (VAS 0-10) in subgroup with AFS ≤40 (severe) at 12 months: | |||
| Walking flat | 0.4 (0.8) | 0.4 (1.6) | 0.00† (−0.52 to 0.52) |
| Walking rough | 1.4 (1.5) | 1.4 (2.5) | 0.00† (−0.52 to 0.52) |
| Mean (SD) instability (VAS 0-10) in subgroup with AFS >40 (mild) at 12 months: | |||
| Walking flat | 0.3 (0.7) | 0.5 (1.5) | −0.17† (−0.75 to 0.41) |
| Walking rough | 0.7 (1.3) | 1.5 (2.6) | −0.39† (−0.98 to 0.19) |
| Wester29 | |||
| No (%) with instability at 230 days | 6 (25) | 0 (0) | NA |
VAS=visual analogue scale; AFS=ankle function score.
*Effect size >0 indicates beneficial effects of supervised treatment; relative risk <1.0 indicates beneficial effects of supervised treatment.
†Effect size.
‡P<0.05.
Results of individual studies with re-sprain as outcome measure classified by duration of follow-up
| Outcome | Conventional treatment | Supervised treatment | Relative risk* (95% CI) |
|---|---|---|---|
| Reinhardt27 | |||
| No (%) with re-sprain at 3 months | 4 (12) | 1 (2) | 0.18 (0.02 to 1.55) |
| Van Rijn20 | |||
| No (%) with re-sprain: | |||
| At 3 months | 14 (27) | 10 (23) | 0.86 (0.43 to 1.75) |
| In subgroup AFS ≤40 (severe) at 8 weeks | 10 (36) | 6 (21) | 0.60 (0.25 to 1.43) |
| In subgroup AFS >40 (mild) at 8 weeks | 2 (8) | 7 (33) | 4.14 (0.97 to 17.95) |
| Holme24 | |||
| No (%) with re-sprain at 12 months | 11 (28.9) | 2 (6.9) | 0.24 (0.06 to 0.99)† |
| Nilsson25 | |||
| No (%) with re-sprain | |||
| At 3-6 months | 5 (9) | 6 (10) | 1.20 (0.39 to 3.72) |
| At 3 years | 9 (18) | 9 (17) | 0.96 (0.42 to 2.23) |
| Van Rijn20 | |||
| No (%) with re-sprain at 12 months: | |||
| Total | 16 (31) | 13 (29) | 0.94 (0.51 to 1.73) |
| In subgroup AFS≤40 (severe) | 12 (43) | 9 (32) | 0.75 (0.38 to 1.49) |
| In subgroup AFS>40 (mild) | 5 (20) | 8 (38) | 1.90 (0.73 to 4.95) |
| Wester29 | |||
| No (%) with re-sprain at 230 days | 13 (54) | 6 (25) | 0.46 (0.21 to 1.01) |
AFS=ankle function score.
*Relative risk <1.0 indicates beneficial effects of supervised treatment.
†P<0.05.
Results of individual studies with recovery as outcome measure classified by duration of follow-up
| Outcome | Conventional treatment | Supervised treatment | Effect size* (95% CI) |
|---|---|---|---|
| Roycroft28 | |||
| Mean recovery period (days) | 18.6 | 11.9 | NA |
| van Rijn20 | |||
| Mean (SD) recovery (VAS 0-10): | |||
| At 3 months | 7.8 (2.4) | 8.2 (2.4) | 0.17 (−0.22 to 0.55) |
| In subgroup AFS ≤40 (severe) at 8 weeks | 6.6 (2.0) | 7.2 (2.1) | 0.29 (−0.24 to 0.82) |
| In subgroup AFS >40 (mild) at 8 weeks | 7.7 (2.3) | 7.0 (2.9) | −0.27 (−0.85 to 0.32) |
| van Rijn20 | |||
| Mean (SD) recovery (VAS 0-10): | |||
| At 12 months | 8.6 (1.9) | 8.3 (2.8) | −0.13 (−0.51 to 0.26) |
| In subgroup AFS ≤40 (severe) at 12 months | 8.7 (1.6) | 8.4 (2.4) | −0.15 (−0.67 to 0.38) |
| In subgroup AFS >40 (mild) at 12 months | 8.7 (2.1) | 9.2 (1.9) | 0.24 (−0.34 to 0.83) |
VAS=visual analogue scale; AFS=ankle function score.
*Effect size >0 indicates beneficial effects of supervised treatment.
Results of individual studies with function as outcome measure classified by duration of follow-up
| Outcome | Conventional treatment | Supervised treatment | Effect size or relative risk* (95% CI) |
|---|---|---|---|
| Basset22 | |||
| Mean (SD) scores at 10-14 days: | |||
| LLTQ recreational | 8.2 (7.2) | 12.0 (10.1) | −0.43† (−1.02 to 0.17) |
| LLTQ ADL | 1.8 (3.9) | 2.3 (3.6) | −0.13† (−0.72 to 0.46) |
| Motor activity scale | 5.7 (1.1) | 5.1 (1.3) | 0.49† (−0.11 to 1.09) |
| Hultman30 | |||
| FAOS at 6 weeks | NA | NA | NA |
| Karlsson21 | |||
| No (%) with excellent results at 12/24 months | 34 (87) | 41 (91) | 0.78 (0.23 to 2.70) |
NA=not applicable; LLTQ=lower limb task questionnaire; ADL=activities of daily living, FAOS=foot and ankle outcome score.
*Effect size >0 indicates beneficial effects of supervised treatment; relative risk <1.0 indicates beneficial effects of supervised treatment.
†Effect size.
Results of individual studies with return to work and sport as outcome measure classified by duration of follow-up
| Outcome | Conventional treatment | Supervised treatment | Effect size or relative risk* (95% CI) |
|---|---|---|---|
| Brooks23 | |||
| No of days off work | 5.1/7.5/14.0† | 6.0 | NA |
| Hultman30 | |||
| Mean (SD) No of days off work | 6.1 (7.4) | 4.6 (6.1) | 0.22‡ (−0.34 to 0.77) |
| Karlsson21 | |||
| Mean (SD) No of days of sick | 10.2 (6.8) | 5.6 (4.2) | 0.82‡ (0.37 to 1.27)§ |
| Nilsson25 | |||
| Mean No of days of sick leave | 12.7 | 11.5 | NA |
| Reinhardt27 | |||
| Mean (SD) days before return to work | 8.7 (3.1) | 5.7 (3.1) | 0.96† (0.49 to 1.43)§ |
| Oostendorp26 | |||
| No (%) who had returned to work: | |||
| At 6 weeks | 10 (85) | 10 (86) | 1.00 (0.70 to 1.43) |
| At 12 weeks | 11 (88) | 11 (91) | 1.00 (0.79 to 1.27) |
| Oostendorp26 | |||
| No (%) who returned to work at 24 weeks | 11 (91) | 11 (94) | 1.00 (0.79 to 1.27) |
| Karlsson21 | |||
| Mean (SD) No of days before return to sports activity | 19.2 (9.5) | 9.6 (4.8) | 1.29† (0.82 to 1.76)§ |
| Reinhardt27 | |||
| Days before return to sports | 13.8 | 11.7 | NA |
| Oostendorp26 | |||
| No (%) who returned to sports training: | |||
| At 6 weeks | 7 (62) | 4 (30) | 0.57 (0.22 to 1.45) |
| At 12 weeks | 11 (88) | 5 (43) | 0.45 (0.23 to 0.91)§ |
| Oostendorp26 | |||
| No (%) who returned to sports training at 24 weeks | 11 (96) | 9 (74) | 0.82 (0.57 to 1.18) |
*Effect size >0 indicates beneficial effects of supervised treatment; relative risk <1.0 indicates beneficial effects of supervised treatment.
†In conventional treatment groups: no treatment, no support, or only minimal bandaging/double Tubigrip worn during day/complete immobilisation of ankle in below knee cast, weight bearing encouraged as soon as possible (see table 2).
‡Effect size.
§P<0.05.